Biofilms and catheter-associated urinary tract infections

Infectious Disease Clinics of North America

Volumn 17, Issue 2, 2003, Pages 411-432

  Saint, Sanjay ^a,b   Chenoweth, Carol E ^c  

^a VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; AMPICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; COAGULASE; COTRIMOXAZOLE; GENTAMICIN; LEVOFLOXACIN; MINOCYCLINE; NITROFURAL; PIPERACILLIN PLUS TAZOBACTAM; POLYSACCHARIDE; QUINOLONE; RIFAMPICIN; SILVER; SULTAMICILLIN; TIMENTIN; TOBRAMYCIN; UREA; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ASEPSIS; BIOFILM; CANDIDA; CATHETER; CLINICAL FEATURE; CLINICAL TRIAL; ENTEROBACTER; ENTEROBACTERIACEAE; ENTEROCOCCUS; ESCHERICHIA COLI; HEALTH CARE COST; HUMAN; HYDROPHOBICITY; INCIDENCE; INDWELLING CATHETER; INTERMITTENT CATHETERIZATION; KLEBSIELLA; MICROBIAL ADHESION; MORBIDITY; MORTALITY; PATIENT SATISFACTION; PROTEUS; PROVIDENCIA; PSEUDOMONAS AERUGINOSA; REVIEW; RISK FACTOR; SUPRAPUBIC CATHETER; URINARY TRACT INFECTION; URINE CATHETER;

EID: 0038609481     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(03)00011-4     Document Type: Review

References (149)

1. Haley RW, Hooton TM, Culver DH, Stanley RC, Emori TG, Hardison CD, et al. Nosocomial infections in US hospitals, 1975-1976: estimated frequency by selected characteristics of patients. Am J Med 1981;70:947-59.
2. Haley RW, Culver DH, White JW, Morgan WM, Emori TG. The nationwide nosocomial infection rate: a new need for vital statistics. Am J Epidemiol 1985;121:159-67.
3. Krieger JN, Kaiser DL, Wenzel RP. Urinary tract etiology of bloodstream infections in hospitalized patients. J Infect Dis 1983;148:57-62.
4. Saint S. Clinical and economic consequences of nosocomial catheter-related bacteriuria. Am J Infect Control 2000;28:68-75.
5. Tambyah PA, Maki DG. Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients. Arch Intern Med 2000;160:678-82.
6. Bryan CS, Reynolds KL. Hospital-acquired bacteremic urinary tract infection: epidemiology and outcome. J Urol 1984;132:494-8.
7. Platt R, Polk BF, Murdock B, Rosner B. Mortality associated with nosocomial urinary-tract infection. N Engl J Med 1982;307:637-42.
8. Platt R, Polk BF, Murdock B, Rosner B. Reduction of mortality associated with nosocomial urinary tract infection. Lancet 1983;1:893-7.
9. Saint S, Lipsky BA, Baker PD, McDonald LL, Ossenkop K. Urinary catheters: What type do men and their nurses prefer? J Am Geriatr Soc 1999;47:1453-7.
10. Saint S, Lipsky BA, Goold SD. Indwelling urinary catheters: A one-point restraint? Ann Intern Med 2002;137:125-7.
11. Jarvis WR. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infect Control Hosp Epidemiol 1996; 17:552-7.
12. Tambyah PA, Knasinski V, Maki DG. The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. Infect Control Hosp Epidemiol 2002;23:27-31.
13. Krieger JN, Kaiser DL, Wenzel RP. Nosocomial urinary tract infections: secular trends, treatment and economics in a university hospital. J Urol 1983;130:102-6.
14. Saint S, Lipsky BA. Preventing catheter-related bacteriuria: Can we? Should we? How? Arch Intern Med 1999;159:800-8.
15. Stark RP, Maki DG. Bacteriuria in the catheterized patient. What quantitative level of bacteriuria is relevant? N Engl J Med 1984;311:560-4.
16. Stamm WE. Urinary tract infections. In: Bennett JV, Brachman PS, editors. Hospitals infections. 4th edition. Philadelphia: Lippincott-Raven; 1998. p. 477-85.
17. Warren JW, Tenney JH, Hoopes JM, Muncie HL, Anthony WC. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis 1982;146:719-23.
18. Warren JW. Catheter-associated urinary tract infections. Infect Dis Clin North Am 1997;11:609-22.
19. Maki DG, Tambyah PA. Engineering out the risk for infection with urinary catheters. Emerg Infect Dis 2001;7:342-7.
20. Dunne WM Jr. Bacterial adhesion: seen any good biofilms lately? Clin Microbiol Rev 2002;15:155-66.
21. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002;15:167-93.
22. Donlan RM. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 2001;33:1387-92.
23. Donlan RM. Biofilms and device-associated infections. Emerg Infect Dis 2001;7:277-81.
24. Donlan RM. Biofilms: microbial life on surfaces. Emerg Infect Dis 2002;8:881-90.
25. Choong SK, Wood S, Whitfield HN. A model to quantify encrustation on ureteric stents, urethral catheters and polymers intended for urological use. BJU Int 2000;86:414-21.
26. Daifuku R, Stamm WE. Association of rectal and urethral colonization with urinary tract infection in patients with indwelling catheters. JAMA 1984;252:2028-30.
27. Stamm WE. Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. Am J Med 1991;91:65S-71S.
28. Tambyah PA, Halvorson KT, Maki DG. A prospective study of pathogenesis of catheter-associated urinary tract infections. Mayo Clin Proc 1999;74:131-6.
29. Tannock GW. The bowel microflora: an important source of urinary tract pathogens. World J Urol 1999;17:339-44.
30. Warren JW. Catheter-associated urinary tract infections. Int J Antimicrob Agents 2001;17:299-303.
31. Pratt LA, Kolter R. Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili. Mol Microbiol 1998;30:285-93.
32. O'Toole GA, Kolter R. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol 1998;30:295-304.
33. Morris NS, Stickler DJ, McLean RJ. The development of bacterial biofilms on indwelling urethral catheters. World J Urol 1999;17:345-50.
34. Choong S, Whitfield H. Biofilms and their role in infections in urology. BJU Int 2000;86:935-41.
35. Stickler DJ, Morris NS, McLean RJ, Fuqua C. Biofilms on indwelling urethral catheters produce quorum-sensing signal molecules in situ and in vitro. Appl Environ Microbiol 1998;64:3486-90.
36. Sabbuba N, Hughes G, Stickler DJ. The migration of Proteus mirabilis and other urinary tract pathogens over Foley catheters. BJU Int 2002;89:55-60.
37. Ganderton L, Chawla J, Winters C, Wimpenny J, Stickler D. Scanning electron microscopy of bacterial biofilms on indwelling bladder catheters. Eur J Clin Microbiol Infect Dis 1992; 11:789-96.
38. Stickler DJ, King JB, Winters C, Morris SL. Blockage of urethral catheters by bacterial biofilms. J Infect 1993;27:133-5.
39. Choong S, Wood S, Fry C, Whitfield H. Catheter associated urinary tract infection and encrustation. Int J Antimicrob Agents 2001;17:305-10.
40. Morris NS, Stickler DJ. Encrustation of indwelling urethral catheters by Proteus mirabilis biofilms growing in human urine. J Hosp Infect 1998;39:227-34.
41. Stickler DJ, Zimakoff J. Complications of urinary tract infections associated with devices used for long-term bladder management. J Hosp Infect 1994;28:177-94.
42. Donlan RM. Role of biofilms in antimicrobial resistance. ASAIO J 2000;46:S47-52.
43. Stickler DJ. Susceptibility of antibiotic-resistant gram-negative bacteria to biocides: a perspective from the study of catheter biofilms. J Appl Microbiol 2002;92:1635-705.
44. Hoyle BD, Wong CK, Costerton JW. Disparate efficacy of tobramycin on Ca(2+)-, Mg(2+)-, and HEPES-treated Pseudomonas aeruginosa biofilms. Can J Microbiol 1992; 38:1214-8.
45. Raz R, Schiller D, Nicolle LE. Chronic indwelling catheter replacement before antimicrobial therapy for symptomatic urinary tract infection. J Urol 2000;164:1254-8.
46. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993;329:1328-34.
47. Kumon H, Hashimoto H, Nishimura M, Monden K, Ono N. Catheter-associated urinary tract infections: impact of catheter materials on their management. Int J Antimicrob Agents 2001;17:311-6.
48. Morris NS, Stickler DJ, Winters C. Which indwelling urethral catheters resist encrustation by Proteus mirabilis biofilms? Br J Urol 1997;80:58-63.
49. Garibaldi RA, Burke JP, Dickman ML, Smith CB. Factors predisposing to bacteriuria during indwelling urethral catheterization. N Engl J Med 1974;291:215-9.
50. Hustinx WN, Mintjes de Groot AJ, Verkooyen RP, Verbrugh HA. Impact of concurrent antimicrobial therapy on catheter-associated urinary tract infection. J Hosp Infect 1991;18:45-56.
51. Platt R, Polk BF, Murdock B, Rosner B. Risk factors for nosocomial urinary tract infection. Am J Epidemiol 1986;124:977-85.
52. Riley DK, Classen DC, Stevens LE, Burke JP. A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. Am J Med 1995;98:349-56.
53. Shapiro M, Simchen E, Izraeli S, Sacks TG. A multivariate analysis of risk factors for acquiring bacteriuria in patients with indwelling urinary catheters for longer than 24 hours. Infect Control 1984;5:525-32.
54. Johnson JR, Roberts PL, Olsen RJ, Moyer KA, Stamm WE. Prevention of catheter-associated urinary tract infection with a silver oxide-coated urinary catheter: clinical and microbiologic correlates. J Infect Dis 1990;162:1145-50.
55. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 2000;21:510-5.
56. Sobel JD, Kauffman CA, McKinsey D, Zervos M, Vazquez JA, Karchmer AW, et al. Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis 2000;30:19-24.
57. Wise GJ, Silver DA. Fungal infections of the genitourinary system. J Urol 1993; 149:1377-88.
58. Ang BS, Telenti A, King B, Steckelberg JM, Wilson WR. Candidemia from a urinary tract source: microbiological aspects and clinical significance. Clin Infect Dis 1993;17:662-6.
59. Wainstein MA, Graham RC Jr., Resnick MI. Predisposing factors of systemic fungal infections of the genitourinary tract. J Urol 1995;154:160-3.
60. Demuth PJ, Gerding DN, Crossley K. Staphylococcus aureus bacteriuria, Arch Intern Med 1979;139:78-80.
61. Saint S, Wiese J, Amory JK, Bernstein ML, Patel UD, Zemencuk JK, et al. Are physicians aware of which of their patients have indwelling urinary catheters? Am J Med 2000;109:476-80.
62. Burket JS, Bartlett RH, Vander Hyde K, Chenoweth CE. Nosocomial infections in adult patients undergoing extracorporeal membrane oxygenation. Clin Infect Dis 1999; 28:828-33.
63. Munasinghe RL, Yazdani H, Siddique M, Hafeez W. Appropriateness of use of indwelling urinary catheters in patients admitted to the medical service. Infect Control Hosp Epidemiol 2001;22:647-9.
64. Hartstein AI, Garber SB, Ward TT, Jones SR, Morthland VH. Nosocomial urinary tract infection: a prospective evaluation of 108 catheterized patients. Infect Control 1981;2:380-6.
65. Gardam MA, Amihod B, Orenstein P, Consolacion N, Miller MA. Overutilization of indwelling urinary catheters and the development of nosocomial urinary tract infections. Clin Perform Qual Health Care 1998;6:99-102.
66. Jain P, Parada JP, David A, Smith LG. Overuse of the indwelling urinary tract catheter in hospitalized medical patients. Arch Intern Med 1995;155:1425-9.
67. Wong ES. Guideline for prevention of catheter-associated urinary tract infections. Am J Infect Control 1983; 11:28-36.
68. Kunin CM. Can we build a better urinary catheter? [editorial] N Engl J Med 1988; 319:365-6.
69. Conybeare A, Pathak S, Imam I. The quality of hospital records of urethral catheterisation. Ann R Coll Surg Engl 2002;84:109-10.
70. Garibaldi RA, Mooney BR, Epstein BJ, Britt MR. An evaluation of daily bacteriologic monitoring to identify preventable episodes of catheter-associated urinary tract infection. Infect Control 1982;3:466-70.
71. Kreger BE, Craven DE, McCabe WR. Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med 1980;68:344-55.
72. Lark RL, Chenoweth CE, Saint S, Zemencuk JK, Lipsky BA, Plorde JJ. Four year prospective evaluation of nosocomial bacteremia: epidemiology, microbiology, and patient outcome. Diagn Microbiol Infect Dis 2000;38:131-40.
73. Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmigiani G, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997;24:584-602.
74. Fisk DT, Saint S, Tierney LM Jr. Clinical problem-solving: back to the basics. N Engl J Med 1999;341:747-50.
75. Biering-Sorensen F, Bagi P, Hoiby N. Urinary tract infections in patients with spinal cord lesions: treatment and prevention. Drugs 2001;61:1275-87.
76. Warren JW. Catheter-associated urinary tract infections. Infect Dis Clin North Am 1987;1:823-54.
77. Siroky MB. Pathogenesis of bacteriuria and infection in the spinal cord injured patient. Am J Med 2002; 113:8.
78. Mombelli G, Pezzoli R, Pinoja-Lutz G, Monotti R, Marone C, Franciolli M. Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: a prospective randomized clinical trial. Arch Intern Med 1999;159:53-8.
79. Pratt RJ, Pellowe C, Loveday HP, Robinson N, Smith GW, Barrett S, et al. The epic project: developing national evidence-based guidelines for preventing healthcare associated infections. Phase I: Guidelines for preventing hospital-acquired infections. Department of Health (England). J Hosp Infect 2001;47:82.
80. Shojania KG, Duncan BW, McDonald KM, Wachter RM. Making health care safer: a critical analysis of patient safety practices. Rockville, MD: AHRQ Publication No. 01E058; 2001.
81. Saint S. Prevention of nosocomial urinary tract infections. In: Shojania KG, Duncan BW, McDonald KM, Wachter RM, editors. Making health care safer: a critical analysis of patient safety practices. Rockville, MD: AHRQ Publication No. 01-E058; 2001. p. 149-62.
82. Burke JP, Larsen RA, Stevens LE. Nosocomial bacteriuria: estimating the potential for prevention by closed sterile urinary drainage. Infect Control Hosp Epidemiol 1986;7(2 suppl):96-9.
83. Zoebelein E, Levy M, Greenwald RA. The effect of quality assurance review on implementation of an automatic stop-order policy. QRB Qual Rev Bull 1982;8:12-7.
84. Cornia PB, Amory JK, Fraser S, Saint S, Lipsky BA. Computer-based order entry decreases duration of indwelling urinary catheterization in hospitalized patients. Am J Med 2003;114:404-7.
85. Wolff G, Gradel E, Buchman B. Indwelling catheter and risk of urinary infection: a clinical investigation with a new closed-drainage system. Urol Res 1976;4:15-8.
86. Thornton GF, Andriole VT. Bacteriuria during indwelling catheter drainage. II. Effect of a closed sterile drainage system. JAMA 1970;214:339-42.
87. Meares EM Jr. Current patterns in nosocomial urinary tract infections. Urology 1991;37(suppl 3):9-12.
88. Kunin CM, McCormack RC. Prevention of catheter-induced urinary-tract infections by sterile closed drainage. N Engl J Med 1966;274:1155-61.
89. Huth TS, Burke JP, Larsen RA, Classen DC, Stevens LE. Clinical trial of junction seals for the prevention of urinary catheter-associated bacteriuria. Arch Intern Med 1992;152:807-12.
90. Schaberg DR, Haley RW, Highsmith AK, Anderson RL, McGowan JE Jr. Nosocomial bacteriuria: a prospective study of case clustering and antimicrobial resistance. Ann Intern Med 1980;93:420-4.
91. Larson EL. APIC guideline for handwashing and hand antisepsis in health care settings. Am J Infect Control 1995;23:251-69.
92. Saint S, Elmore JG, Sullivan SD, Emerson SS, Koepsell TD. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis. Am J Med 1998;105:236-41.
93. Verleyen P, De Ridder D, Van Poppel H, Baert L. Clinical application of the Bardex IC Foley catheter. Eur Urol 1999;36:240-6.
94. Thibon P, Le Coutour X, Leroyer R, Fabry J. Randomized multi-centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital-acquired urinary tract infections. J Hosp Infect 2000;45:117-24.
95. Newton T, Still JM, Law E. A comparison of the effect of early insertion of standard latex and silver-impregnated latex Foley catheters on urinary tract infections in burn patients. Infect Control Hosp Epidemiol 2002;23:217-8.
96. Karchmer TB, Giannetta ET, Muto CA, Strain BA, Farr BM. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch Intern Med 2000;160:3294-8.
97. Bologna RA, Tu LM, Polansky M, Fraimow HD, Gordon DA, Whitmore KE. Hydrogel/ silver ion-coated urinary catheter reduces nosocomial urinary tract infection rates in intensive care unit patients: a multicenter study. Urology 1999;54:982-7.
98. Maki DG, Knasinski V, Halvorson K, Tambyah PA. A novel silver-hydrogel-impregnated indwelling urinary catheter reduces catheter-related urinary tract infections: a prospective double-blind trial [abstract]. Infect Control Hosp Epidemiol 1998;19:682(A10).
99. Saint S, Veenstra DL, Sullivan SD, Chenoweth C, Fendrick AM. The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection. Arch Intern Med 2000;160:2670-5.
100. Plowman R, Graves N, Esquivel J, Roberts JA. An economic model to assess the cost and benefits of the routine use of silver alloy coated urinary catheters to reduce the risk of urinary tract infections in catheterized patients. J Hosp Infect 2001;48:33-42.
101. Darouiche RO, Smith JA Jr., Hanna H, Dhabuwala CB, Steiner MS, Babaian RJ, et al. Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial. Urology 1999;54:976-81.
102. Cho YH, Lee SJ, Lee JY, Kim SW, Kwon IC, Chung SY, et al. Prophylactic efficacy of a new gentamicin-releasing urethral catheter in short-term catheterized rabbits. BJU Int 2001;87:104-9.
103. van der Wall E, Verkooyen RP, Mintjes de Groot J, Oostinga J, van Dijk A, Hustinx WN, et al. Prophylactic ciprofloxacin for catheter-associated urinary-tract infection [see comments]. Lancet 1992;339:946-51.
104. Verbrugh HA, Mintjes de Groot AJ, Andriesse R, Hamersma K, van Dijk A. Postoperative prophylaxis with norfloxacin in patients requiring bladder catheters. Eur J Clin Microbiol Infect Dis 1988;7:490-4.
105. Vollaard EJ, Clasener HA, Zambon JV, Joosten HJ, van Griethuysen AJ. Prevention of catheter-associated gram-negative bacilluria with norfloxacin by selective decontamination of the bowel and high urinary concentration. J Antimicrob Chemother 1989;23:915-22.
106. Mountokalakis T, Skounakis M, Tselentis J. Short-term versus prolonged systemic antibiotic prophylaxis in patients treated with indwelling catheters. J Urol 1985;134:506-8.
107. Little PJ, Pearson S, Peddie BA, Greenslade NF, Utley WL. Amoxicillin in the prevention of catheter-induced urinary infection. J Infect Dis 1974;129:S241-2.
108. Britt MR, Garibaldi RA, Miller WA, Hebertson RM, Burke JP. Antimicrobial prophylaxis for catheter-associated bacteriuria. Antimicrob Agents Chemother 1977;11:240-3.
109. Platt R, Polk BF, Murdock B, Rosner B. Prevention of catheter-associated urinary tract infection: a cost-benefit analysis. Infect Control Hosp Epidemiol 1989;10:60-4.
110. Tolkoff Rubin NE, Cosimi AB, Russell PS, Rubin RH. A controlled study of trimethoprim-sulfamethoxazole prophylaxis of urinary tract infection in renal transplant recipients. Rev Infect Dis 1982;4:614-8.
111. Fox BC, Sollinger HW, Belzer FO, Maki DG. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis. Am J Med 1990;89:255-74.
112. Amin M. Antibacterial prophylaxis in urology: a review. Am J Med 1992;92:114S-7S.
113. Johnson DE, Muncie HL, O'Reilly JL, Warren JW. An external urine collection device for incontinent women: evaluation of long-term use. J Am Geriatr Soc 1990;38:1016-22.
114. Hirsh DD, Fainstein V, Musher DM. Do condom catheter collecting systems cause urinary tract infection? JAMA 1979;242:340-1.
115. Ouslander JG, Greengold B, Chen S. Complications of chronic indwelling urinary catheters among male nursing home patients: a prospective study. J Urol 1987;138:1191-5.
116. Ouslander JG, Greengold B, Chen S. External catheter use and urinary tract infections among incontinent male nursing home patients. J Am Geriatr Soc 1987;35:1063-70.
117. Zimakoff J, Stickler DJ, Pontoppidan B, Larsen SO. Bladder management and urinary tract infections in Danish hospitals, nursing homes, and home care: a national prevalence study. Infect Control Hosp Epidemiol 1996;17:215-21.
118. Warren JW. Urethral catheters, condom catheters, and nosocomial urinary tract infections. Infect Control Hosp Epidemiol 1996;17:212-4.
119. The prevention and management of urinary tract infections among people with spinal cord injuries. National Institute on Disability and Rehabilitation Research Consensus Statement. January 27-29, 1992. J Am Paraplegia Soc 1992;15:194-204.
120. Kuhn W, Rist M, Zaech GA. Intermittent urethral self-catheterisation: long term results (bacteriological evolution, continence, acceptance, complications). Paraplegia 1991;29:222-32.
121. Lapides J, Diokno AC, Silber SJ, Lowe BS. Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol 1972;107:458-61.
122. Lapides J, Diokno AC, Lowe BS, Kalish MD. Follow-up on unsterile intermittent self-catheterization. J Urol 1974;111:184-7.
123. Diokno AC, Sonda LP, Hollander JB, Lapides J. Fate of patients started on clean intermittent self-catheterization therapy 10 years ago. J Urol 1983;129:1120-2.
124. Pearman JW. Urological follow-up of 99 spinal cord injured patients initially managed by intermittent catheterisation. Br J Urol 1976;48:297-310.
125. Weld KJ, Dmochowski RR. Effect of bladder management on urological complications in spinal cord injured patients. J Urol 2000;163:768-72.
126. Bennett CJ, Young MN, Adkins RH, Diaz F. Comparison of bladder management complication outcomes in female spinal cord injury patients. J Urol 1995;153:1458-60.
127. Cardenas DD, Hooton TM. Urinary tract infection in persons with spinal cord injury. Arch Phys Med Rehabil 1995;76:272-80.
128. Shekelle PG, Morton SC, Clark KA, Pathak M, Vickrey BG. Systematic review of risk factors for urinary tract infection in adults with spinal cord dysfunction. J Spinal Cord Med 1999;22:258-72.
129. Jamil F. Towards a catheter free status in neurogenic bladder dysfunction: a review of bladder management options in spinal cord injury (SCI). Spinal Cord 2001;39:355-61.
130. Horgan AF, Prasad B, Waldron DJ, O'Sullivan DC. Acute urinary retention: comparison of suprapubic and urethral catheterisation. Br J Urol 1992;70:149-51.
131. Shapiro J, Hoffmann J, Jersky J. A comparison of suprapubic and transurethral drainage for postoperative urinary retention in general surgical patients. Acta Chir Scand 1982;148:323-7.
132. Andersen JT, Heisterberg L, Hebjorn S, Petersen K, Stampe Sorensen S, Fischer Rasmussen W, et al. Suprapubic versus transurethral bladder drainage after colposuspension/vaginal repair. Acta Obstet Gynecol Scand 1985;64:139-43.
133. Sethia KK, Selkon JB, Berry AR, Turner CM, Kettlewell MG, Gough MH. Prospective randomized controlled trial of urethral versus suprapubic catheterization. Br J Surg 1987;74:624-5.
134. O'Kelly TJ, Mathew A, Ross S, Munro A. Optimum method for urinary drainage in major abdominal surgery: a prospective randomized trial of suprapubic versus urethral catheterization. Br J Surg 1995;82:1367-8.
135. Schiotz HA, Malme PA, Tanbo TG. Urinary tract infections and asymptomatic bacteriuria after vaginal plastic surgery: a comparison of suprapubic and transurethral catheters. Acta Obstet Gynecol Scand 1989;68:453-5.
136. Johnson TM, Ouslander JG, Uman GC, Schnelle JF. Urinary incontinence treatment preferences in long-term care. J Am Geriatr Soc 2001;49:710-8.
137. Warren JW, Platt R, Thomas RJ, Rosner B, Kass EH. Antibiotic irrigation and catheter-associated urinary-tract infections. N Engl J Med 1978;299:570-3.
138. Kirk D, Dunn M, Bullock DW, Mitchell JP, Hobbs SJ. Hibitane bladder irrigation in the prevention of catheter-associated urinary infection. Br J Urol 1979;51:528-31.
139. Gelman ML. Antibiotic irrigation and catheter-associated urinary tract infections [editorial]. Nephron 1980;25:259.
140. Dudley MN, Barriere SL. Antimicrobial irrigations in the prevention and treatment of catheter-related urinary tract infections. Am J Hosp Pharm 1981;38:59-65.
141. Bastable JR, Peel RN, Birch DM, Richards B. Continuous irrigation of the bladder after prostatectomy: its effect on post-prostatectomy infection. Br J Urol 1977;49:689-93.
142. Sweet DE, Goodpasture HC, Holl K, Smart S, Alexander H, Hedari A. Evaluation of H2O2 prophylaxis of bacteriuria in patients with long-term indwelling Foley catheters: a randomized controlled study. Infect Control 1985;6:263-6.
143. Thompson RL, Haley CE, Searcy MA, Guenthner SM, Kaiser DL, Groschel DH, et al. Catheter-associated bacteriuria: failure to reduce attack rates using periodic instillations of a disinfectant into urinary drainage systems. JAMA 1984;251:747-51.
144. Gillespie WA, Simpson RA, Jones JE, Nashef L, Teasdale C, Speller DC. Does the addition of disinfectant to urine drainage bags prevent infection in catheterised patients? Lancet 1983;1:1037-9.
145. Burke JP, Garibaldi RA, Britt MR, Jacobson JA, Conti M, Alling DW. Prevention of catheter-associated urinary tract infections: efficacy of daily meatal care regimens. Am J Med 1981;70:655-8.
146. Burke JP, Jacobson JA, Garibaldi RA, Conti MT, Alling DW. Evaluation of daily meatal care with poly-antibiotic ointment in prevention of urinary catheter-associated bacteriuria. J Urol 1983;129:331-4.
147. Ichsan J, Hunt DR. Suprapubic catheters: a comparison of suprapubic versus urethral catheters in the treatment of acute urinary retention. Aust N Z J Surg 1987;57:33-6.
148. Ratnaval CD, Renwick P, Farouk R, Monson JR, Lee PW. Suprapubic versus transurethral catheterisation of males undergoing pelvic colorectal surgery. Int J Colorectal Dis 1996;11:177-9.
149. Perrin LC, Penfold C, McLeish A. A prospective randomized controlled trial comparing suprapubic with urethral catheterization in rectal surgery. Aust N Z J Surg 1997;67:554-6.